Published On : 10 july 2025
CAGR Value :
• The global novel benzodiazepine receptor agonists market size was valued at USD 138 million in 2024. The market is projected to grow from USD 158 million in 2025 to USD 306 million by 2032, exhibiting a CAGR of 12.1% during the forecast period.
Email: help@intelmarketresearch.com +91 9169164321
• Novel benzodiazepine receptor agonists are a class of psychoactive drugs that selectively target GABAA receptors in the central nervous system. These nextgeneration compounds demonstrate improved therapeutic profiles compared to traditional benzodiazepines, with applications spanning anxiety disorders, insomnia treatment, and epilepsy management. Key differentiating factors include reduced cognitive impairment, lower abuse potential, and minimized next-day sedation effects addressingmajorlimitationsofconventionaltherapies.
Email: help@intelmarketresearch.com +91 9169164321
By Types
Benzodiazepine
Agonists
By Applications
• Insomnia Treatment
• Generalized Anxiety Disorder (GAD)
• Panic Disorders
• Sedation (Pre-Anesthesia)
• Other Neurological Disorders
Email: help@intelmarketresearch.com +91
Key Players :
•Zhejiang Jingxin Pharmaceutical (China)
•Evotec SE (Germany)
•Jiangsu Hengrui Medicine Co., Ltd. (China)
•Paion AG (Germany)
•Neurim Pharmaceuticals (Israel)
•Sun Pharma Advanced Research Company (India)
•Taisho Pharmaceutical Holdings (Japan)
Email: help@intelmarketresearch.com +91 9169164321
